Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review

[url="]Imagion Biosystems, Ltd. (ASX: IBX)[/url] has announced that the US Food and Drug Administration (FDA) completed its review of the company's investigati